CClinicalTrials.gg
Status unknownNCT02420249Updated Dec 15, 2015

Qigong for Breast Cancer Survivors

An interventional study of Qigong training in Neoplasms, sponsored by The University of Hong Kong. Status unknown at 1 site in Hong Kong. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-12-15.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2015), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Objectives: (1) To investigate the effects of Qigong training on upper limb oedema, circulatory status, shoulder flexibility and muscular strength, body balance, and quality of life (QOL) in community-dwelling breast cancer survivors; and (2) to explore the relationship between the impairment outcomes and QOL outcomes.

Hypothesis: (1) The experimental participants will have less impairment and a better QOL after Qigong training compared with the no-training control group; and (2) the impairment parameters will be related to the QOL indexes in the Qigong participants.

Design and subjects: This will be a prospective, randomised, single-blinded controlled trial. Approximately 60 breast cancer survivors will be randomly assigned to either the Qigong training group (n\~30) or control group (n\~30).

Intervention: Participants in the Qigong group will receive 18 Forms of Tai Chi Internal Qigong training for 3 months with two supervised 1-hour sessions per week.

Main outcome measures: The primary outcome measures are upper limb circumference, arterial blood flow velocities and resistance index, shoulder joint passive range of motion, muscular strength (peak force) and body balance. The secondary outcome measure is quality of life as measured by the Functional Assessment of Cancer Therapy - Breast scale.

Data analysis: Data will be analysed via repeated-measures analysis of variance followed by post-hoc tests (α = 0.05).

Expected results: The investigators pilot studies produced encouraging results on the efficacy of Qigong exercise in reducing chronic breast cancer-related symptoms in survivors. Therefore, the investigators expect that participants in the Qigong group will have fewer upper limb impairments and a better quality of life after Qigong training. If the results are positive, this Qigong training regime is readily transferrable to clinical practice, and could have positive socioeconomic effects such as reduced healthcare costs.

02

Conditions studied

  • Neoplasms
03

In context

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

The inclusion criteria are

  1. history of a breast malignancy of any stage
  2. history of mastectomy or lumpectomy with or without adjuvant chemotherapy or radiotherapy
  3. having completed conventional cancer treatment and medically stable
  4. no known neurological deficits resulting from breast cancer treatment or other neurological disorders
  5. persistent lymphoedema defined as a circumference difference greater than 2 cm at any point between the surgical upper limb and contralateral upper limb13
  6. female aged 18 or above.

Exclusion criteria

Exclusion Criteria:

The exclusion criteria are

  1. presence of major psychiatric, neurological, musculoskeletal, cardiovascular, peripheral vascular or kidney disorder
  2. receiving conventional cancer treatments such as chemotherapy or radiotherapy, medications such as diuretics or traditional Chinese medicine
  3. recurrent cancer or cancer that has spread to another organ
  4. participation in regular physical activity
  5. prior experience of Qigong or Tai Chi
  6. a smoking habit
  7. pregnancy during the study period.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Qigong training group

    Participants assigned to the Qigong group will receive Qigong training. The Qigong training programme will be run for 3 months with two supervised 1-hour sessions per week. Participants will learn the 18 Forms of Tai Chi Internal Qigong. The training sessions will be conducted by a qualified Qigong instructor from the Natural Health Qigong Association. Participants in the control group will receive no Qigong training during the study period. They will receive an 18 Forms of Tai Chi Internal Qigong training package after the study.

    Behavioral: Qigong training

  • No intervention
    Control group

    Participants in the control group will receive no Qigong training.

Interventions

  • BehavioralQigong training

    Participants will learn the 18 Forms of Tai Chi Internal Qigong. Detailed movement and breathing descriptions of the Qigong training protocol can been found in Mak YK. 18 Forms Tai Chi Qigong \[in Chinese\]. 7th ed. Hong Kong: Wan Li Book Co.; 2012.

06

What researchers measure

Primary outcomes

  1. Change in upper limb circumference

    Circumference of both arms will be measured using a cloth measuring tape.

    Time frame: Baseline (0 month) and post-intervention (3 months)

  2. Change in arterial resistance and blood flow velocities

    A Doppler ultrasound machine will be used to examine the arterial blood flow velocities.

    Time frame: Baseline (0 month) and post-intervention (3 months)

  3. Change in shoulder flexibility

    A universal goniometer will be used to measure the passive range of motion (ROM) of bilateral shoulder abduction and horizontal abduction.

    Time frame: Baseline (0 month) and post-intervention (3 months)

  4. Change in shoulder muscular strength

    The maximum isometric muscular strength of the shoulder flexor, abductor, internal rotator and external rotator muscles will be measured bilaterally using the Lafayette Manual Muscle Test System.

    Time frame: Baseline (0 month) and post-intervention (3 months)

  5. Change in body balance

    Standing balance of the participants will be measured using timed single leg standing test.

    Time frame: Baseline (0 month) and post-intervention (3 months)

Secondary outcomes

  1. Change in quality of life

    Functional Assessment of Cancer Therapy - Breast scale version 4 will be used.

    Time frame: Baseline (0 month) and post-intervention (3 months)

07

Study locations

1 of 1 sites recruiting
  • University of Hong Kong
    Pokfulam, Hong Kong
    • Shirley SM Fong, PT, PhD · Contact · smfong@hku.hk · 852-97090337
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02420249
Lead sponsor
The University of Hong Kong
Responsible party
Shirley S.M. Fong (Assistant Professor, DRPC chairperson, The University of Hong Kong) — Principal investigator
First posted
Apr 17, 2015
Start date
Mar 2015
Primary completion
May 2017 (estimated)
Last update
Dec 15, 2015

Study contacts

Shirley SM Fong, PhD
Contact
smfong@hku.hk
85297090337

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion